Pfizer Steps Back From Early-Stage Rare Disease R&D

January 12, 2023

Oncopeptides’ Pepaxto to Remain Sidelined From the U.S. Market

September 30, 2022

Philips Launches New Platform to Improve Health Monitoring

October 12, 2023

Must Read

Can AI Predict Regulatory Outcomes in Pharma and Biotech?

April 15, 2026

Market Access Challenges in Pharmaceuticals: Pricing, Policy, and Payer Pressure

April 15, 2026

Why Is Market Access Becoming More Difficult for Pharma Companies?

April 15, 2026

About Us

Life Sciences Voice is the leading resource for life sciences executives to get crucial insights, explore the latest innovations, and learn about industry trends. Life Sciences Voice provides the community with thought-provoking commentary in multiple formats covering a range of issues from drug discovery to commercial success.

Avalyn Files for IPO to Fund Late-Stage Development of Inhaled Lung Disease Therapies

Merck Pays $20 Million Upfront to Access Quotient’s Somatic Genomics Platform for IBD Research

Merck Gets $700M Funding From Blackstone For Cancer Therapy R&D

Pfizer to Withdraw Vyndaqel in the U.S. Before Patent Expiration in 2028

Travere’s Filspari becomes the first FDA-approved medication for FSGS

IDEAYA and Servier Report Phase 2/3 Trial Success for Darovasertib Combination in Uveal Melanoma

Revolution Meets Key Survival Goals With RAS Inhibitor In Important Trial

Tepezza Sales Dip Slightly as Subcutaneous Formulation Shows Late-Stage Efficacy

Regeneron Partners with Telix in Radiopharmaceutical Collaboration Covering Up to Eight Cancer Programs

OrbiMed Announces $137M Series B Financing For Sidewinder

Roche Commits $20 Million Upfront and Over $1 Billion in Milestones in C4 Therapeutics DAC Partnership

Chugai and Gero Partner to Develop Antibodies for Age-Related Diseases Using AI

J&J MedTech presents the first Ottava surgical robot clinical cases

Wisp Launches Weight Care Vertical for Women with Hormonal Imbalances

PicnicHealth Launches New Service Bringing Observational Clinical Trials to the Virtual Realm

Can AI Predict Regulatory Outcomes in Pharma and Biotech?

Market Access Challenges in Pharmaceuticals: Pricing, Policy, and Payer Pressure

Why Is Market Access Becoming More Difficult for Pharma Companies?

Launch Readiness in Pharma: Overcoming Market Entry Barriers

Tag: toprolCamber pharmaceuticals

Camber Pharmaceuticals to bring generic Toprol XL to the market

Editor Picks

Pfizer Steps Back From Early-Stage Rare Disease R&D

Oncopeptides’ Pepaxto to Remain Sidelined From the U.S. Market

Philips Launches New Platform to Improve Health Monitoring

Must Read

Can AI Predict Regulatory Outcomes in Pharma and Biotech?

Market Access Challenges in Pharmaceuticals: Pricing, Policy, and Payer Pressure

Why Is Market Access Becoming More Difficult for Pharma Companies?

Hot Topics

About Us

Follow Us